Peripheral blood T lymphocyte sensitisation against calsequestrin and flavoprotein in patients with Graves' ophthalmopathy

Autoimmunity

Volumn 41, Issue 5, 2008, Pages 372-376

  Nguyen, Bao ^a   Gopinath, Bamini ^a   Tani, Junichi ^a   Wescombe, Leon ^a   Wall, Jack R ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Calsequestrin; Flavoprotein; Graves' disease; Lymphocyte proliferation assay; T cells; Thyroid associated ophthalmopathy

Indexed keywords

CALSEQUESTRIN; FLAVOPROTEIN; G2S ANTIGEN; MUSCLE ANTIGEN;

ADULT; AGED; ARTICLE; CELL CYCLE; CELLULAR DISTRIBUTION; CELLULAR IMMUNITY; CHRONIC DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOCRINE OPHTHALMOPATHY; EXTRAOCULAR MUSCLE; FEMALE; GRAVES DISEASE; HUMAN; HYPERTHYROIDISM; IMMUNOREACTIVITY; INFLAMMATION; LYMPHOCYTE FUNCTION; LYMPHOCYTE PROLIFERATION; MALE; MUSCLE CELL; PROTEIN LOCALIZATION; PROTEIN TARGETING; T LYMPHOCYTE ACTIVATION;

ADULT; AGED; CALSEQUESTRIN; CELL PROLIFERATION; CHRONIC DISEASE; EYE PROTEINS; FEMALE; FLAVOPROTEINS; GRAVES DISEASE; GRAVES OPHTHALMOPATHY; HUMANS; LYMPHOCYTE ACTIVATION; MALE; MEMBRANE PROTEINS; MIDDLE AGED; T-LYMPHOCYTES;

EID: 45949088474     PISSN: 08916934     EISSN: 1607842X     Source Type: Journal    
DOI: 10.1080/08916930801931142     Document Type: Article

References (31)

1. Yamada, M., Li, AW and Wall, JR (2000) Thyroid-associated ophthalmopathy: Clinical features, pathogenesis, and management. Crit Rev Clin Lab Sci, 37, pp. 523-549.
2. El-Kaissi, S., Frauman, AG and Wall, JR (2004) Thyroid-associated ophthalmopathy: A practical guide to classification, natural history and management. Intern Med J, 34, pp. 482-491.
3. Burch, HB and Wartofsky, L. (1993) Graves' ophthalmopathy: Current concepts regarding pathogenesis and management. Endocr Rev, 14, pp. 747-793.
4. Gopinath, B., Adams, CL, Musselman, R., Tani, J. and Wall, JR (2007) Antibodies against calsequestrin and type XIII collagen are good markers for chronic upper eyelid retraction. Ocul Immunol Inflamm, 15, pp. 81-88.
5. Gopinath, B., Musselman, R., Adams, CL, Tani, J., Beard, N. and Wall, JR (2006) Study of serum antibodies against three eye muscle antigens and the connective tissue antigen collagen XIII in patients with Graves' disease with and without ophthalmopathy-correlation with clinical features. Thyroid, 16, pp. 967-974.
6. Gopinath, B., Musselman, R., Beard, N., El-Kaissi, S., Tani, J., Adams, CL and Wall, JR (2006) Antibodies targeting the calcium binding skeletal muscle protein calsequestrin are specific markers of ophthalmopathy and sensitive indicators of ocular myopathy in patients with Graves' disease. Clin Exp Immunol, 145, pp. 56-62.
7. Tani, J. and Wall, JR (2006) Autoimmunity against eye-muscle antigens may explain thyroid-associated ophthalmopathy. CMAJ, 175, p. 239.
8. Weetman, AP, Cohen, S., Gatter, KC, Fells, P. and Shine, B. (1989) Immunohistochemical analysis of the retrobulbar tissues in Graves' ophthalmopathy. Clin Exp Immunol, 75, pp. 222-227.
9. Pappa, A., Lawson, JM, Calder, V., Fells, P. and Lightman, S. (2000) T cells and fibroblasts in affected extraocular muscles in early and late thyroid associated ophthalmopathy. Br J Ophthalmol, 84, pp. 517-522.
10. Forster, G., Otto, E., Hansen, C., Ochs, K. and Kahaly, G. (1998) Analysis of orbital T cells in thyroid-associated ophthalmopathy. Clin Exp Immunol, 112, pp. 427-434.
11. de Carli, M., D'Elios, MM, Mariotti, S., Marcocci, C., Pinchera, A., Ricci, M., Romagnani, S. and del Prete, G (1993) Cytolytic T cells with Th1-like cytokine profile predominate in retroorbital lymphocytic infiltrates of Graves' ophthalmopathy. J Clin Endocrinol Metab, 77, pp. 1120-1124.
12. Kahaly, G., Stover, C., Otto, E., Beyer, J. and Schuler, M. (1992) Glycosaminoglycans in thyroid-associated ophthalmopathy. Autoimmunity, 13, pp. 81-88.
13. Hansen, C., Otto, E., Kuhlemann, K., Forster, G. and Kahaly, GJ (1996) Glycosaminoglycans in autoimmunity. Clin Exp Rheumatol, 14, pp. S59-S67.
14. Otto, E., Ochs, K., Leyendecker, E., Gentsch, A., Hansen, C., Beyer, J. and Kahaly, G. (1995) Autoimmune endocrine ophthalmopathy and retrobulbar antigens. Horm Metab Res, 27, pp. 533-538.
15. Tan, GH, Dutton, CM and Bahn, RS (1996) Interleukin-1 (IL-1) receptor antagonist and soluble IL-1 receptor inhibit IL-1-induced glycosaminoglycan production in cultured human orbital fibroblasts from patients with Graves' ophthalmopathy. J Clin Endocrinol Metab, 81, pp. 449-452.
16. Otto, EA, Ochs, K., Hansen, C., Wall, JR and Kahaly, GJ (1996) Orbital tissue-derived T lymphocytes from patients with Graves' ophthalmopathy recognize autologous orbital antigens. J Clin Endocrinol Metab, 81, pp. 3045-3050.
17. Wall, JR, Trewin, A., Fang, SL, Ingbar, SH and Braverman, LE (1978) Studies of immunoreactivity to human lacrimal gland fractions in patients with ophthalmic Graves' disease. J Endocrinol Invest, 1, pp. 253-258.
18. Wall, JR, Walters, BA and Grant, C. (1979) Leukocyte adherence inhibition in response to human orbital and lacrimal extracts in patients with Graves' ophthalmopathy. J Endocrinol Invest, 2, pp. 375-378.
19. Arnold, K., Tandon, N., McIntosh, RS, Elisei, R., Ludgate, M. and Weetman, AP (1994) T cell responses to orbital antigens in thyroid-associated ophthalmopathy. Clin Exp Immunol, 96, pp. 329-334.
20. Chang, CH, Yamada, M., Blanchard, ME, Li, AW and Wall, JR (2002) Peripheral blood lymphocyte transformation to G2s in patients with autoimmune thyroid disease with and without ophthalmopathy. Autoimmunity, 35, pp. 313-317.
21. Gunji, K., Kubota, S., Stolarski, C., Wengrowicz, S., Kennerdell, JS and Wall, JR (1999) A 63 kDa skeletal muscle protein associated with eye muscle inflammation in Graves' disease is identified as the calcium binding protein calsequestrin. Autoimmunity, 29, pp. 1-9.
22. Kubota, S., Gunji, K. Ackrell, BA et al. (1998) The 64-kilodalton eye muscle protein is the flavoprotein subunit of mitochondrial succinate dehydrogenase: The corresponding serum antibodies are good markers of an immune-mediated damage to the eye muscle in patients with Graves' hyperthyroidism. J Clin Endocrinol Metab, 83, pp. 443-447.
23. Gunji, K., De Bellis, A. Li, AW et al. (2000) Cloning and characterization of the novel thyroid and eye muscle shared protein G2s: Autoantibodies against G2s are closely associated with ophthalmopathy in patients with Graves' hyperthyroidism. J Clin Endocrinol Metab, 85, pp. 1641-1647.
24. Nunery, WR, Martin, RT, Heinz, GW and Gavin, TJ (1993) The association of cigarette smoking with clinical subtypes of ophthalmic Graves' disease. Ophthal Plast Reconstr Surg, 9, pp. 77-82.
25. Mourits, MP, Koornneef, L., Wiersinga, WM, Prummel, MF, Berghout, A. and van der Gaag, R. (1989) Clinical criteria for the assessment of disease activity in Graves' ophthalmopathy: A novel approach. Br J Ophthalmol, 73, pp. 639-644.
26. Paschke, R., Vassart, G. and Ludgate, M. (1995) Current evidence for and against the TSH receptor being the common antigen in Graves' disease and thyroid associated ophthalmopathy. Clin Endocrinol (Oxf), 42, pp. 565-569.
27. Bahn, RS (2003) Clinical review 157: Pathophysiology of Graves' ophthalmopathy: The cycle of disease. J Clin Endocrinol Metab, 88, pp. 1939-1946.
28. Porter, JD, Khanna, S. Kaminski, HJ et al. (2001) Extraocular muscle is defined by a fundamentally distinct gene expression profile. Proc Natl Acad Sci USA, 98, pp. 12062-12067.
29. Fliegel, L., Burns, K., Wlasichuk, K. and Michalak, M. (1989) Peripheral membrane proteins of sarcoplasmic and endoplasmic reticulum. Comparison of carboxyl-terminal amino acid sequences. Biochem Cell Biol, 67, pp. 696-702.
30. De Bellis, A., Sansone, D. Coronella, C. et al. (2005) Serum antibodies to collagen XIII: A further good marker of active Graves' ophthalmopathy. Clin Endocrinol, 62, pp. 24-29.
31. De Bellis, A., Sansone, D. Coronella, C. et al. (2005) Serum antibodies to collagen XIII: A further good marker of active Graves' ophthalmopathy. Clin Endocrinol (Oxf), 62, pp. 24-29.